Allergan Says Court Botched Facts In Botox Antitrust Suit
Allergan Inc. on Monday asked a California federal judge to reconsider its refusal to dismiss a suit accusing Allergan of keeping prices for Botox artificially high by buying rights for a...To view the full article, register now.
Already a subscriber? Click here to view full article